<< Read Full Article
<< Read Full Article
I've pulled just two letters from the Biotech Mailbag this week -- on Biogen Idec(BIIB Quote) and Isis Pharmaceuticals(ISIS Quote) -- because my responses turned out to be rather lengthy. But these stocks are very newsworthy, so enjoy.
Carl M. writes: "Longtime reader and holder of Biogen Idec. Through all the ups and downs. Are you hearing anything about Icahn's plans or any interest in the sale of the company? As you know it popped to $84 and has pulled back on no news. Just would appreciate anything you are hearing on the company." ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,464.40 | 1,110.63 | 2,176.05 | 32.79 |
Oil *
77.05
|
|
UP
30.69
|
UP
4.98
|
UP
6.87
|
DOWN
0.38
|
10 Yr
3.28%
SPDR Gold
116.62
|
|
+0.29%
|
+0.45%
|
+0.32%
|
-1.15%
|
Data delayed 20 minutes |
Connect with TheStreet